Does TACROLIMUS Cause Neoplasm malignant? 271 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 271 reports of Neoplasm malignant have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.3% of all adverse event reports for TACROLIMUS.
271
Reports of Neoplasm malignant with TACROLIMUS
0.3%
of all TACROLIMUS reports
140
Deaths
61
Hospitalizations
How Dangerous Is Neoplasm malignant From TACROLIMUS?
Of the 271 reports, 140 (51.7%) resulted in death, 61 (22.5%) required hospitalization, and 6 (2.2%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 271 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TACROLIMUS Alternatives Have Lower Neoplasm malignant Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB